Incidence of Immune Checkpoint Inhibitor-Associated Diabetes: A Meta-Analysis of Randomized Controlled Studies
Background: Immune checkpoint inhibitors (ICIs) are now an important option for more than 14 different cancers. Recent series case reports have described that ICIs are associated with new-onset diabetes in patients, yet the definitive risk is not available. We thus performed a meta-analysis of rando...
Saved in:
Main Authors: | Jingli Lu (Author), Jing Yang (Author), Yan Liang (Author), Haiyang Meng (Author), Junjie Zhao (Author), Xiaojian Zhang (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2019-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Concomitant use of renin-angiotensin system inhibitors augments the efficacy of immune checkpoint inhibitors: a systematic review and meta-analysis
by: Junjie Yu, et al.
Published: (2024) -
Immune Checkpoint Inhibitor-Associated Tumor Lysis Syndrome: A Real-World Pharmacovigilance Study
by: Li Wang, et al.
Published: (2021) -
Immune Checkpoint Inhibitor Toxicity in Head and Neck Cancer: From Identification to Management
by: Haiyang Wang, et al.
Published: (2019) -
The Relative Risk and Incidence of Immune Checkpoint Inhibitors Related Pneumonitis in Patients With Advanced Cancer: A Meta-Analysis
by: Ke Ma, et al.
Published: (2018) -
Risk Factors, Incidence, and Prognosis of Thromboembolism in Cancer Patients Treated With Immune Checkpoint Inhibitors
by: Xue-lin Zou, et al.
Published: (2021)